|
業務類別
|
Biotechnology |
|
業務概覽
|
Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points.The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses. |
| 公司地址
| Two Tower Place, 7th Floor, South San Francisco, CA, USA, 94080 |
| 電話號碼
| +1 833 509-4583 |
| 傳真號碼
| +1 317 663-2462 |
| 公司網頁
| https://www.assemblybio.com |
| 員工數量
| 73 |
| Ms. Jeanette M. Bjorkquist |
Principal Financial Officer, Principal Accounting Officer and Vice President, Finance |
-- |
19/03/2026 |
| Mr. Nicole S. White, PhD |
Chief Manufacturing Officer |
-- |
22/04/2026 |
| Mr. Jason A. Okazaki |
Director, President, Chief Executive Officer |
美元 647.50K |
22/04/2026 |
| Mr. William E. Delaney, IV,PhD |
Chief Scientific Officer |
美元 511.33K |
22/04/2026 |
| Mr. John O. Gunderson |
Vice President, General Counsel and Corporate Secretary |
-- |
09/06/2025 |
| Mr. Anuj Gaggar, M.D.,PhD |
Chief Medical Officer |
美元 502.86K |
22/04/2026 |
|
|
| Mr. Anthony E. Altig |
Independent Director |
22/04/2026 |
| Mr. William R. Ringo, Jr |
Chairman of the Board |
22/04/2026 |
| Dr. Susan Mahony, M.B.A.,PhD |
Independent Director |
22/04/2026 |
| Ms. Gina Consylman |
Independent Director |
22/04/2026 |
| Mr. Jason A. Okazaki |
Director, President, Chief Executive Officer |
22/04/2026 |
| Dr. John G. McHutchison, A.O.,M.D. |
Independent Director |
22/04/2026 |
| Mr. Robert D. Cook, II |
Director |
22/04/2026 |
| Dr. Lisa R. Johnson-Pratt, M.D. |
Independent Director |
22/04/2026 |
| Dr. Tomas Cihlar, PhD |
Director |
22/04/2026 |
| Sir Michael Houghton, PhD |
Independent Director |
22/04/2026 |
|
|
|
|
